Sze Lin Yoong1, Tara Clinton-McHarg2, Luke Wolfenden2. 1. Hunter New England Population Health, Hunter New England Local Health District, Booth Building, Longworth Avenue, Wallsend, New South Wales 2287, Australia; School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia; Priority Research Centre for Health Behaviour, The University of Newcastle, Callaghan, New South Wales 2308, Australia. Electronic address: Serene.Yoong@hnehealth.nsw.gov.au. 2. Hunter New England Population Health, Hunter New England Local Health District, Booth Building, Longworth Avenue, Wallsend, New South Wales 2287, Australia; School of Medicine and Public Health, The University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia; Priority Research Centre for Health Behaviour, The University of Newcastle, Callaghan, New South Wales 2308, Australia.
Abstract
OBJECTIVES: To examine the research translation phase focus (T1-T4) of systematic reviews published in the Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE). Briefly, T1 includes reviews of basic science experiments; T2 includes reviews of human trials leading to guideline development; T3 includes reviews examining how to move guidelines into policy and practice; and T4 includes reviews describing the impact of changing health practices on population outcomes. STUDY DESIGN AND SETTING: A cross-sectional audit of randomly selected reviews from CDSR (n = 500) and DARE (n = 500) was undertaken. The research translation phase of reviews, overall and by communicable disease, noncommunicable disease, and injury subgroups, were coded by two researchers. RESULTS: A total of 898 reviews examined a communicable, noncommunicable, or injury-related condition. Of those, 98% of reviews within CDSR focused on T2, and the remaining 2% focused on T3. In DARE, 88% focused on T2, 8.7% focused on T1, 2.5% focused on T3, and 1.3% focused on T4. Almost all reviews examining communicable (CDSR 100%, DARE 93%), noncommunicable (CDSR 98%, DARE 87%), and injury (CDSR 95%, DARE 88%) were also T2 focused. CONCLUSION: Few reviews exist to guide practitioners and policy makers with implementing evidence-based treatments or programs.
OBJECTIVES: To examine the research translation phase focus (T1-T4) of systematic reviews published in the Cochrane Database of Systematic Reviews (CDSR) and Database of Abstracts of Reviews of Effects (DARE). Briefly, T1 includes reviews of basic science experiments; T2 includes reviews of human trials leading to guideline development; T3 includes reviews examining how to move guidelines into policy and practice; and T4 includes reviews describing the impact of changing health practices on population outcomes. STUDY DESIGN AND SETTING: A cross-sectional audit of randomly selected reviews from CDSR (n = 500) and DARE (n = 500) was undertaken. The research translation phase of reviews, overall and by communicable disease, noncommunicable disease, and injury subgroups, were coded by two researchers. RESULTS: A total of 898 reviews examined a communicable, noncommunicable, or injury-related condition. Of those, 98% of reviews within CDSR focused on T2, and the remaining 2% focused on T3. In DARE, 88% focused on T2, 8.7% focused on T1, 2.5% focused on T3, and 1.3% focused on T4. Almost all reviews examining communicable (CDSR 100%, DARE 93%), noncommunicable (CDSR 98%, DARE 87%), and injury (CDSR 95%, DARE 88%) were also T2 focused. CONCLUSION: Few reviews exist to guide practitioners and policy makers with implementing evidence-based treatments or programs.
Authors: Alexandra P Metse; John H Wiggers; Paula M Wye; Luke Wolfenden; Judith J Prochaska; Emily A Stockings; Jill M Williams; Kerryn Ansell; Caitlin Fehily; Jenny A Bowman Journal: Nicotine Tob Res Date: 2016-11-10 Impact factor: 4.244
Authors: George A Mensah; Cheryl Anne Boyce; LeShawndra N Price; Helena O Mishoe; Michael M Engelgau Journal: Ethn Dis Date: 2017-12-07 Impact factor: 1.847
Authors: Melinda M Davis; Michele Freeman; Jackilen Shannon; Gloria D Coronado; Kurt C Stange; Jeanne-Marie Guise; Stephanie B Wheeler; David I Buckley Journal: BMC Cancer Date: 2018-01-06 Impact factor: 4.430
Authors: Abel Kho; Gail L Daumit; Kimberly P Truesdale; Arleen Brown; Amy M Kilbourne; Joseph Ladapo; Soma Wali; Lisa Cicutto; Alicia K Matthews; Justin D Smith; Paris D Davis; Antoinette Schoenthaler; Gbenga Ogedegbe; Nadia Islam; Katherine T Mills; Jiang He; Karriem S Watson; Robert A Winn; June Stevens; Amy G Huebschmann; Stanley J Szefler Journal: Health Serv Res Date: 2022-06 Impact factor: 3.734
Authors: Arkers Kwan Ching Wong; Frances Kam Yuet Wong; Martin Chi Sang Wong; Karen Kit Sum Chow; Dilys Kwai Sin Kwan; Dubby Yun Sang Lau Journal: BMC Geriatr Date: 2022-10-07 Impact factor: 4.070
Authors: Andrew Searles; Chris Doran; John Attia; Darryl Knight; John Wiggers; Simon Deeming; Joerg Mattes; Brad Webb; Steve Hannan; Rod Ling; Kim Edmunds; Penny Reeves; Michael Nilsson Journal: Health Res Policy Syst Date: 2016-08-09
Authors: Samuel Cassar; Jo Salmon; Anna Timperio; Patti-Jean Naylor; Femke van Nassau; Ana María Contardo Ayala; Harriet Koorts Journal: Int J Behav Nutr Phys Act Date: 2019-12-02 Impact factor: 6.457